The Sézary syndrome: hematologic criteria.
The hematologic criteria for Sézary syndrome that were recently proposed by the International Society on Cutaneous Lymphomas are critically evaluated. Based on the experience at two institutions, revisions to the definition for Sézary syndrome are proposed.
Vonderheid
Eric C
EC
Department of Dermatology, Johns Hopkins Medical Institutions, 550 North Broadway, Suite 1002, Baltimore, MD 21205, USA. evonder1@jhmi.edu
Bernengo
Maria Grazia
MG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D016516:CD4-CD8 Ratio; D002999:Clone Cells / Q000473:pathology; D003873:Dermatitis, Exfoliative / Q000209:etiology; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating; D014411:Neoplastic Stem Cells / Q000473:pathology; D012751:Sezary Syndrome / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D012878:Skin Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000473:pathology
D014408:Biomarkers, Tumor